The Chamber of Commerce & Industry of India (CCI India), in partnership with The Medical Travel Company (TMTC), organised a high-level dialogue at the Taj Mansingh in New Delhi to launch a landmark white paper titled “The New Geography of Care.” The report highlights how economic factors, long treatment wait times, and advances in technology are reshaping global healthcare access and positioning India as a leading destination for advanced medical treatment.
The event drew participation from more than 27 ambassadors representing countries including Yemen, Iraq, Kenya, Guyana, Morocco, Rwanda, Vietnam, Belarus, Armenia and the Arab League. Senior executives and healthcare leaders from major Indian hospital groups such as Medanta, Max Healthcare, Apollo Hospitals, Manipal Hospitals, Fortis Healthcare and Narayana Health also attended the discussion.
The white paper notes that healthcare systems across the world are experiencing mounting structural pressures. Ageing populations, the growing burden of non-communicable diseases and limited clinical capacity have created significant barriers to timely care. For example, the United Kingdom currently faces elective treatment waiting lists exceeding 7-8 million patients, while countries like Canada, Australia and several European nations report long delays for procedures such as joint replacements, cancer treatment and specialist consultations. In the United States, high healthcare costs where spending accounts for nearly 18% of GDP remain a major obstacle for patients.
These challenges are driving what the report describes as a “new geography of care,” where patients increasingly seek cross-border medical treatment not as a last resort but as a practical option for timely and effective care.
Against this global backdrop, India is emerging as a strong healthcare destination. CCI India highlighted the country’s strengths in advanced medical treatments, highly skilled specialists and cost-efficient healthcare services. These factors continue to attract international patients seeking reliable, high-quality treatment.
The dialogue also underscored India’s growing reputation in holistic wellness, supported by global interest in traditional practices such as Ayurveda, yoga and naturopathy.
According to the white paper, India holds a unique advantage in serving as a high-quality, high-volume partner for global health systems. Complex procedures in areas such as cardiology, orthopaedics and oncology are often available in India at costs 40-90% lower than those in the United States, the United Kingdom and Europe. In addition, many Indian hospital networks operate specialised Centres of Excellence that deliver outcomes comparable to global benchmarks. Investments in technologies such as robotic surgery, precision radiotherapy, digital health systems and multidisciplinary care models have further strengthened India’s capabilities.
Following the Covid-19 pandemic, India has also seen an increase in patients from countries such as the United Kingdom, Australia and Canada who are seeking quicker access to guideline-based treatments.
The white paper emphasises that India’s opportunity lies in establishing itself as a global benchmark for ethical and well-governed Medical Value Travel. This would involve strong accreditation systems, transparent bundled pricing models, structured aftercare and interoperable digital health records.
TMTC’s leadership stressed the importance of creating a structured and clinically supervised pathway for international patients. The report highlights ongoing challenges in the global medical tourism ecosystem, including lack of price transparency, unregulated intermediaries, inconsistent diagnostics, unclear “fit-to-fly” standards and limited follow-up care once patients return home.
Sahil Jain, Co-Founder and CEO of TMTC, said that many patients today face long waiting periods in their home countries while also encountering uncertainty when seeking treatment abroad. He noted that TMTC aims to address these issues by providing a structured, end-to-end system that ensures safety, continuity of care and reliable outcomes.
Munindra Kumar, Director General of CCI India, emphasised the need for a coordinated ecosystem involving hospitals, travel providers, insurers and government agencies to deliver consistent and predictable healthcare experiences for international patients.
CCI India reiterated its commitment to strengthening India’s position as a trusted global destination for medical and wellness tourism, while encouraging initiatives that foster international collaboration and growth in the healthcare sector.
The event concluded with a networking session that brought together ambassadors, healthcare leaders and global partners to explore new opportunities for cooperation and to expand bilateral medical corridors between India and other countries.
